It was found that a high serum level of CXCL13 protein is a potential good prognosis indicator for hepatocellular carcinoma, but it was also found to be associated with a poor prognosis in patients with prostate cancer and breast cancer [28]. This evidence concerns the gene CXCL13 and hepatocellular carcinoma.